Interleukin-6 overexpression cannot generate serious disorders in severe combined immunodeficiency mice

Clinical Immunology and Immunopathology

Volumn 82, Issue 2, 1997, Pages 117-124

  Katsume, Asao ^a   Miyai, Tatsuya ^a   Suzuki, Hiroshi ^a   Moriguchi, Yoshiyuki ^a   Kawata, Hiromitsu ^a   Tatsumi, Tetsuo ^a   Suematsu, Sachiko ^b   Kishimoto, Tadamitsu ^b   Ohsugi, Yoshiyuki ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; GENE REARRANGEMENT; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MOUSE; NONHUMAN; PLASMACYTOSIS; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0031080815     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.4278     Document Type: Article

References (29)

1. 1. Taga, T., and Kishimoto, T., Role of a two-chain IL-6 receptor system in immune and hematopoietic cell regulation. Crit. Rev. Immunol. 11, 265-280, 1992.
2. 2. Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimizu, M., Murashima, A., Tsunasawa, S., Sakiyama, F., and Kishimoto, T., Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur. J. Immunol. 18, 1797-1801, 1988.
3. 3. Houssiau, F. A., Devogelaer, J. P., Damme, J. V., de Deuxchaicnes, C. N., and Snick, J. V., Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritis. Arthritis Rheum. 31, 784-788, 1988.
4. 4. Yoshizaki, K., Matsuda, T., Nishimoto, N., Kuritani, T., Taeho, L., Aozasa, K., Nakahata, T., Kawai, H., Tagoh, H., Komori, T., Kishimoto, S., Hirano, T., and Kishimoto, T., Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74, 1360-1367, 1989.
5. 5. Brant, S. J., Bodine, D. M., Dunbar, C. E., and Nienhuis, A. W., Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J. Clin. Invest. 86, 592-599, 1990.
6. 6. Suematsu, S., Matsuda, T., Aozasa, K., Akira, S., Nakano, N., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T., and Kishimoto, T., IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. USA 86, 7547-7551, 1989.
7. 7. Suematsu, S., Matsusaka, T., Matsuda, T., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T., and Kishimoto, T., Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. USA 89, 232-235, 1992.
8. 8. Horii, Y., Iwano, M., Hirata, E., Shiiki, M., Fujii, Y., Dohi, K., and Ishikawa, H., Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int. Suppl. 39, S71-75, 1993.
9. 9. Ohta, K., Takano, N., Seno, A., Yachie, A., Miyawaki, T., Yokoyama, H., Tomosugi, N., Kato, E., and Taniguchi, N., Detection and clinical usefulness of urinary interleukin-6 in the diseases of kidney and the urinary tract. Clin. Nephrol. (Germany) 38, 185-189, 1992.
10. 10. Fukatsu, A., Matsuo, S., Tamai, H., Sakamoto, N., Matsuda, T., and Hirano, T., Distribution of interleukin-6 in normal and diseased human kidney. Lab. Invest. 65, 61-66, 1991.
11. 11. Horii, Y., Muraguchi, A., Iwano, M., Matsuda, T., Hirayama, T., Yamada, H., Fujii, Y., Dohi, K., Ishikawa, H., Ohmoto, Y., Yoshizaki, K., Hirano, T., and Kishimoto, T., Involvement of IL-6 in mesangial proliferative glomerulonephritis. J. Immunol. 143, 3949-3955, 1989.
12. 12. Strasser, A., Harris, A. W., Corcoran, L. M., and Cory, S., Bcl-2 expression promotes B-but not T-lymphoid development in scid mice. Nature 368, 457-460, 1994.
13. 13. Bosma, G. C., Custer, R. P., and Bosma, M. J., A severe combined immunodeficiency mutation in mice. Nature 301, 527-530, 1983.
14. 14. Bosma, M. J., and Carroll, A. M., The scid mutant: Definition, characterization, and potential uses. Annu. Rev. Immunol. 9, 323-350, 1991.
15. 15. Roth, D. B., Menetski, J. P., Nakajima, P. B., Bosma, M. J., and Gellert, M., V(D)J recombination-broken DNA molecules with covalently sealed (hairpin) coded ends in scid mouse thymocytes. Cell 70, 983-991, 1992.
16. 16. Yamamura, K., Kikutani, H., Takahashi, N., Taga, T., Akira, S., Kawai, K., Fukuchi, K., Kumahara, Y., Honjo, T., and Kishimoto, T., Introduction of human gamma 1 immunoglobulin genes into fertilized mouse eggs. J. Biochem. (Tokyo) 96, 357-363, 1984.
17. 17. Matsuda, T., Hirano, T., and Kishimoto, T., Establishment of an interleukin 6 (IL6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL6 monoclonal antibodies. Eur. J. Immunol. 18, 951-956, 1988.
18. 18. Suzuki, H., Shingai, S., Togashi, M., Miyai, T., and Okamoto, M., In vitro fertilization and the development of eggs following transfer in genetically diabetic obese (ob/ob) mouse. Jpn. J. Anim. Reprod. 33, 96-100, 1987.
19. 19. Arnheiter, H., Skuntz, S., Noteborn, M., Chang, S., and Meier, E., Transgenic mice with intracellular immunity to influenza virus. Cell 62, 51-61, 1990.
20. 20. Woodroofe, C., Muller, W., and Ruther, U., Long-term consequences of interleukin-6 overexpression in transgenic mice. DNA Cell. Biol. 11, 587-592, 1992.
21. 21. Taga, T., Kawanishi, K., Hardy, R. R., Hirano, T., and Kishimoto, T., Receptor for B cell stimulatory factor 2 (BSF-2): Quantitation, specificity, distribution and regulation of the expression. J. Exp. Med. 166, 967-981, 1987.
22. 22. Muraguchi, A., Hirano, T., Tang, B., Matsuda, T., Horii, Y., Nakajima, K., and Kishimoto, T., The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J. Exp. Med. 167, 332-344, 1988.
23. 23. Takatsuki, F., Okano, A., Suzuki, C., Chieda, R., Takahara, Y., Hirano, T., Kishimoto, T., Hamuro, J., and Akiyama, Y., Human recombinant IL-6/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo. J. Immunol. 141, 3072-3077, 1988.
24. 24. Mihara, M., Koishihara, Y., Fukui, H., Yasukawa, K., and Ohsugi, Y., Murine anti-human IL-6 monoclonal antibody prolongs the bioactivity of human IL-6 in mice. Immunology 74, 55-59, 1991.
25. 25. Bosma, G. C., Fried, M., Custer, R. P., Carroll, A., Gibson, D. M., and Bosma, M. J., Evidence of functional lymphocytes in some (leaky) scid mice. J. Exp. Med. 167, 1016-1033, 1988.
26. 26. Ishibashi, T., Kimura, H., Uchida, T., Kariyone, S., Friese, P., and Burstein, S. A., Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proc. Natl. Acad. Sci. USA 86, 5953-5957, 1989.
27. 27. Ishibashi, T., Kimura, H., Shikama, Y., Uchida, T., Kariyone, S., Hirano, T., Kishimoto, T., Takatsuki, F., and Akiyama, Y., Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 74, 1241-1244, 1989.
28. 28. Ishibashi, T., Shikama, Y., Kimura, H., Kawaguchi, M., Uchida, T., Yamamoto, T., Okano, A., Akiyama, Y., Hirano, T., Kishimoto, T., and Maruyama, Y., Thrombopoietic effects of interleukin-6 in long-term administration in mice. Exp. Hematol. 21, 640-646, 1993.
29. 29. Hawley, R. G., Fong, A. Z., Burns, B. F., and Hawley, T. S., Transplantable myeloproliferative disease induced in mice by an interleukin-6 retrovirus. J. Exp. Med. 176, 1149-1163, 1992.